Nationwide Recall: ByHeart Pulls All Baby Formula Products After Botulism Cases Surge
For parents across the United States, November 2025 brought unsettling news. ByHeart, a well-known manufacturer of organic infant formula, announced a nationwide recall of all its products after federal health agencies linked the brand to a growing outbreak of infant botulism. This decision was not taken lightly: at least 15 babies in 12 states have been hospitalized since August, and the investigation remains ongoing. The recall includes both ByHeart Whole Nutrition Infant Formula cans and the Anywhere Pack single-serve sticks, leaving thousands of families searching for safe alternatives overnight.
Tracing the Outbreak: What Is Infant Botulism and Why Is It So Dangerous?
Infant botulism is a rare but serious illness, caused by the bacterium Clostridium botulinum. The spores from this bacterium can survive in harsh conditions and, under the right circumstances, produce a toxin that attacks the nervous system. According to the Centers for Disease Control and Prevention (CDC), infants under one year old are especially vulnerable because their gut microbiomes are not fully developed. Symptoms can escalate quickly and may include constipation, poor feeding, drooping eyelid, weak muscle tone, and difficulty breathing. If left untreated, botulism can be life-threatening. The only approved treatment is BabyBIG, an intravenous medication made from blood plasma of immunized individuals.
Since August, the U.S. Food and Drug Administration (FDA) has documented over 80 cases of infant botulism nationwide, with at least 36 linked to infant formula. ByHeart’s products have been disproportionately represented among sick infants, despite only making up roughly 1% of the U.S. formula market, raising alarms among regulators and medical professionals.
Inside the Recall: Company Response and Federal Investigation
ByHeart initially recalled two batches of formula on November 8 after being notified of the outbreak by the FDA. But just days later, following additional cases and mounting pressure, the company broadened the recall to all products on November 11. In a public letter, cofounders Mia Funt and Ron Belldegrun emphasized that “your baby’s safety is, and always will be, our biggest priority.” They noted that, to date, neither ByHeart nor federal agencies have found botulinum spores or toxins in any unopened cans, but a contaminated sample was found in an open can fed to a sick infant in California.
The company’s decision to expand the recall came after a late-night call from the FDA, revealing two new cases in babies who had consumed ByHeart formula. The FDA has been conducting inspections at the company’s Portland, Oregon facility, and ByHeart says it is cooperating fully by providing unrestricted access to all products and facilities. The company is also implementing independent third-party testing of every formula batch to ensure safety moving forward.
Impact on Families: What Should Parents Do Now?
With the recall affecting roughly 200,000 cans sold monthly at major retailers like Target, Walmart, Albertsons, and Whole Foods, the disruption is enormous. Parents and caregivers are urged to immediately discontinue use and dispose of any ByHeart formula products. For those facing shortages, ByHeart has provided resources and support to help families find alternative formulas. The company has set up a dedicated helpline and email contact for concerned consumers, and the FDA encourages anyone experiencing adverse reactions to report them through its MedWatch program.
The situation has left many families scrambling. For some, the recall triggered frantic searches for safe formula, compounded by memories of previous formula shortages. Pediatricians are advising parents to monitor infants closely for symptoms and seek immediate medical attention if any signs of botulism appear. The CDC reiterates that no deaths have been reported so far, but swift intervention is crucial.
Looking Ahead: Ongoing Investigation and Lessons Learned
As of mid-November, the FDA, CDC, and state health departments continue to investigate the outbreak. The focus remains on identifying the source of contamination and preventing further cases. The recall will remain in effect until health officials are confident that the risk is eliminated. For ByHeart, the ordeal is a stark reminder of the challenges and responsibilities that come with feeding the nation’s most vulnerable.
Health experts say the outbreak highlights the importance of rigorous safety protocols in the manufacturing and distribution of infant formula. While ByHeart’s proactive recall and transparency have earned cautious praise, the situation underscores the need for ongoing vigilance across the industry. As families adapt and await answers, the hope is that lessons learned will lead to stronger protections for babies everywhere.
The ByHeart recall stands as a critical moment for consumer safety in the U.S. baby formula market. While the company’s swift response and federal oversight have likely prevented further harm, the incident spotlights vulnerabilities in supply chains and regulatory systems. Continued investigation and transparent communication will be essential for rebuilding trust and ensuring the health of the nation’s youngest citizens.